THE MUCOLIPIDOSIS TYPE IV FOUNDATION OPERATES TO RAISE CONTRIBUTIONS FROM INDIVIDUALS AND COMPANIES IN ORDER TO FUND MEDICAL RESEARCH GRANTS. ALL MEDICAL RESERACH GRANTS ARE PROVIDED TO RESEARCHERS STUDYING THE CAUSE AND SYMPTOMS OF MUCOLIPIDOSIS TYPE IV WITH THE HOPE OF FINDING A CURE FOR THIS DISEASE.
Executive compensation, broken down
Form 990 · Part VII & Schedule J · 1 reported individual · Filing year 2024
Percentile bands compare each position's total pay with the same role at Diseases, Disorders & Medical Disciplines organizations nationwide.
- Base
- $195k
- Bonus
- $13k
- Other
- —
- Benefits
- —
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
Executive Director 75th to 90th percentile | $195k | $13k | — | — | $214k $223k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with Atlanta-Sandy Springs-Roswell, GA metro-area CPI-U, restating filed pay into April 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 6 unpaid individuals.
Browse compensation in Diseases, Disorders & Medical Disciplines →
Top pay as a share of expenses
In 2024, the highest total compensation at MUCOLIPIDOSIS TYPE IV FOUNDATION INC equaled 7% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.
Based on 2,393 diseases, disorders & medical disciplines organizations, each measured at its most recent filing year with reported expenses and compensation.
Funded by
Private foundations whose Form 990-PF Part XV grants matched this organization.
Up 8%
from 2023
From $198k in 2023 to $214k in 2024.
Estimated with Atlanta-Sandy Springs-Roswell, GA metro-area CPI-U, restating filed pay into April 2026 dollars. A restatement of past pay, not current or projected pay.
Chief Executive Officer pay rose 8% from 2023 to 2024, while revenue rose 249%.
Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Common questions about MUCOLIPIDOSIS TYPE IV FOUNDATION INC
What does the Chief Executive Officer of MUCOLIPIDOSIS TYPE IV FOUNDATION INC earn?
In 2024, the Chief Executive Officer of MUCOLIPIDOSIS TYPE IV FOUNDATION INC received $213,815 in total compensation. This pay is in the top quarter for Chief Executive Officer roles among Diseases, Disorders & Medical Disciplines organizations nationwide, though not the top 10% of comparable filings. Based on IRS Form 990 data.
How does Chief Executive Officer pay at MUCOLIPIDOSIS TYPE IV FOUNDATION INC compare with similar nonprofits?
Compared with the same role at Diseases, Disorders & Medical Disciplines organizations nationwide, the 2024 pay of the Chief Executive Officer at MUCOLIPIDOSIS TYPE IV FOUNDATION INC falls between the 75th and 90th percentiles. In 2024, the highest total compensation at MUCOLIPIDOSIS TYPE IV FOUNDATION INC equaled 7% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.
What are MUCOLIPIDOSIS TYPE IV FOUNDATION INC's revenue and expenses?
In 2024, MUCOLIPIDOSIS TYPE IV FOUNDATION INC reported $3.8M in total revenue and $3.1M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read moreAre Nonprofit Salaries Public?
What IRS Form 990 discloses about executive compensation, who has to report it, and how to look it up.
Read more